Home
Ensoma, Inc.

Ensoma, Inc. Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainensoma.com

Year Founded2019

Employees51 - 200

Annual Revenue$10M - $15M

Ensoma, Inc.

Ensoma, Inc. (including company regionals)

ensoma.com

See more website traffic and engagement information

Ensoma, Inc. Revenue up to June 2026 is 10M - 15M

revenue generated by Ensoma, Inc. top domains

Ensoma, Inc. top domains revenue over 3 years

Revenue for Ensoma, Inc. top domains

ensoma.com10M - 15M

See more with Sales Intelligence

Total visits to Ensoma, Inc.'s top domains

Understand Ensoma, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ensoma.com4.5K

See more with Sales Intelligence

Avg. visit duration in Ensoma, Inc.'s top domains

Analyze Ensoma, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ensoma.com00:00:47

See more with Sales Intelligence

Avg. pageviews on Ensoma, Inc.'s top domains

See how Ensoma, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ensoma.com1.72

See more with Sales Intelligence

Ensoma, Inc. top competitors by domain

Top similar sites in June 2026, ranked by their affinity

vedantabio.comCompany NameVedanta BiosciencesEmployees51 - 200HQUnited States, Massachusetts, CambridgeAnnual revenue$15M - $25MTotal visits4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Ensoma, Inc.

These are the website technologies, by industry, used by Ensoma, Inc. top domains

Widget (4)

Twemoji

Email Services (2)

G Suite

Mobile (2)

Meta Viewport

Advertising (1)

PubMatic

More Technologies

10

See all

News & Signals from Ensoma, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEnsoma, Inc. attends event Society for Immunotherapy of Cancer Annual Meeting.Ensoma to present new preclinical data at the Society for Immunotherapy of Cancer Annual Meeting.

NewsEnsoma, Inc. received financing of $53M on Sep 29th '25.Avenzo Therapeutics and Ensoma topped off their pools of private funding on Monday, with the former raising a $60-million series B and the latter bringing in $53 million.

NewsEnsoma, Inc. hires Jim Burns as chief executive officer.Ensoma appoints accomplished company builder and product developer, Jim Burns, Ph.D., as chief executive officer.